Sometimes I make snap judgements off a name, probably shouldn't, but this guy sounds smart! -->Israel Englander and his Millennium fund disclose 5.2% passive stake in MacroGenics Sep. 02, 2022 6:01 PM ET MacroGenics, Inc. (MGNX)
Monday-> MacroGenics price target raised to $16 from $13 at Citi 05:08 MGNX Citi analyst Yigal Nochomovitz raised the firm's price target on MacroGenics to $16 from $13 and keeps a Buy rating on the shares. The analyst updated the company's model post the Q2 results.
Even a downgrade points to massive upside. MacroGenics price target lowered to $8 from $18 at Barclays 08/09 MGNX Barclays analyst Peter Lawson lowered the firm's price target on MacroGenics to $8 from $18 and keeps an Overweight rating on the shares post the Q2 results. A 15% reduction in workforce and closure of two satellite offices helps extend the company's cash runway into 2024, Lawson tells investors in a research note. The analyst still sees significant upside in the shares.
Woa wait up I meant that ' bitchy ' comment in a completely positive way. In no manner was that an exact description but a mere snap judgement based off pursed lips--- This is obviously a great human being, Israel Englander is a billionaire hedge fund manager and one of the wealthiest people in the world with a net worth valued at$11.3 billionas of August 2022.
Well two way to look at this: A) This guy can afford to lose his investment and he wouldn't even hardly feel it.- We are not so lucky. B) This guy obviously gets great research and probably has a guy in the basement doing biotech coverage who use to work at Goldman.. (just guessing) but one of the the worlds richest men says I'm in on a $4 bio then so am I! /// Got To research the actual company next week.
yes! i was actually traveling in canada for much of august. amazing. now getting ready *hopefully* for a big autumn in the otc custodial market. a strange racket that market is. hope all is well with you guys.